-
In October, 5 Class 1 new drugs were reported for production, and 7 varieties were approved for new indications
Time of Update: 2023-01-06
Overall CDE Undertaking According to the statistics of Minai. com China Declaration Progress (MED) database, CDE undertook a total of 975 drug registration applications in October 2022. Status of CDE
-
Another domestic anti-cancer new drug approved for marketing!
Time of Update: 2023-01-06
, Ltd. announced that the company's self-developed new anti-cancer class 1 drug linperlisib has been approved by China's National Medical Products Administration (NMPA) on November 9, targeting the treatment of relapsed/refractory (R/R) follicular lymphoma (FL) under the trade name Intaru.
-
Internet rumor that a certain cabin hospital in Chongqing will charge? Official response: No charge
Time of Update: 2023-01-06
(End) In response to the news that a certain cabin hospital in Chongqing was going to charge on the Internet, at the press conference on epidemic prevention and control held by the Information Office of Chongqing Municipal Government on the 20th, Li Bian, deputy director of the Chongqing Municipal Health Commission, refuted the rumor that the cabin hospital did not charge.
-
Internet rumor that a certain cabin hospital in Chongqing will charge? Official response: No charge
Time of Update: 2023-01-06
(End) In response to the news that a certain cabin hospital in Chongqing was going to charge on the Internet, at the press conference on epidemic prevention and control held by the Information Office of Chongqing Municipal Government on the 20th, Li Bian, deputy director of the Chongqing Municipal Health Commission, refuted the rumor that the cabin hospital did not charge.
-
Panoramic interpretation of mRNA nanomedicines: latest progress, challenges, clinical translation and future directions
Time of Update: 2023-01-06
Their successful development has stimulated new and strong research interest in mRNA engineering and delivery technologies, providing unprecedented promise for the clinical translation of various mRNA-based therapies.
-
Panoramic interpretation of mRNA nanomedicines: latest progress, challenges, clinical translation and future directions
Time of Update: 2023-01-06
Their successful development has stimulated new and strong research interest in mRNA engineering and delivery technologies, providing unprecedented promise for the clinical translation of various mRNA-based therapies.
-
15 billion digestion market, Top20 proprietary Chinese medicines announced (with list)
Time of Update: 2023-01-06
2022E Top 20 Proprietary Drug Brands in the Digestive System of Chinese Urban Physical Pharmacies (: 100 million yuan)Source: Competition pattern of drug terminals in China's urban physical pharmacies Note: Less than 100 million yuan is indicated by * The sales of 17 brands exceeded 100 million yuan, and Taiji Group's Chongqing Fuling Pharmaceutical's Huoxiang Zhengqi Oral Liquid, Jiangzhong Pharmaceutical's Stomach Digestion Tablets, and Zhangzhou Pian Zixi Pharmaceutical's Pian Zixi ranked in the top three.
-
15 billion digestion market, Top20 proprietary Chinese medicines announced (with list)
Time of Update: 2023-01-06
2022E Top 20 Proprietary Drug Brands in the Digestive System of Chinese Urban Physical Pharmacies (: 100 million yuan)Source: Competition pattern of drug terminals in China's urban physical pharmacies Note: Less than 100 million yuan is indicated by * The sales of 17 brands exceeded 100 million yuan, and Taiji Group's Chongqing Fuling Pharmaceutical's Huoxiang Zhengqi Oral Liquid, Jiangzhong Pharmaceutical's Stomach Digestion Tablets, and Zhangzhou Pian Zixi Pharmaceutical's Pian Zixi ranked in the top three.
-
PHEXCOM successfully completed the quality audit of JRS Spain factory (sodium stearin fumarate).
Time of Update: 2023-01-05
On November 16, PHEXCOM successfully completed the quality audit of JRS Spain factory.
On November 16, PHEXCOM successfully completed the quality audit of JRS Spain factory.
On November 16, PHEXCOM successfully completed the quality audit of JRS Spain factory.
-
During the year, thousands of executives in the A-share biomedical industry have left
Time of Update: 2023-01-05
js?cdnversion='+~(-new Date()/36e5)];In the pharmaceutical industry, the departure of senior executives of pharmaceutical companies has long become the norm, and since November this year, there have been many more cases, mostly due to personal reasons.
-
Structure determines function, and the key physicochemical properties of adhesives help tablets form perfectly Webinar replay
Time of Update: 2023-01-05
Ashland Pharmaceutical Excipients Webinar· The playback structure determines the function, and the key physical and chemical properties of the adhesive help the tablet to form perfectly Dr. Yi Liu is
-
During the year, the amount of additional funds raised by the three pharmaceutical companies exceeded 3.5 billion yuan, of which one exceeded 10 billion yuan
Time of Update: 2023-01-05
Aier Ophthalmology: A total of approximately RMB3,536 million was raised during the year Aier Eye released the results of the fixed increase on November 11, showing that the number of shares issued was about 133 million shares at a price of 26.
-
Recently, pharmaceutical companies have been selling assets and stopping pipelines
Time of Update: 2023-01-05
In addition to selling assets, pharmaceutical companies are keen to shut down pipelines to reduce operating costs and develop more valuable pipelines, the industry said.
In addition to selling assets, pharmaceutical companies are keen to shut down pipelines to reduce operating costs and develop more valuable pipelines, the industry said.
-
What's next for the pharmaceutical sector? Innovative pharmaceutical companies are optimistic about the industry
Time of Update: 2023-01-05
js?cdnversion='+~(-new Date()/36e5)];Recently, the pharmaceutical sector has risen strongly.
js?cdnversion='+~(-new Date()/36e5)];Recently, the pharmaceutical sector has risen strongly.
js?cdnversion='+~(-new Date()/36e5)];Recently, the pharmaceutical sector has risen strongly.
js?cdnversion='+~(-new Date()/36e5)];Recently, the pharmaceutical sector has risen strongly.
-
The press conference of the joint prevention and control mechanism of the State Council responded to the focus issue
Time of Update: 2023-01-05
Recently, the comprehensive group of the joint prevention and control mechanism of the State Council has deployed and dispatched all localities to promote the implementation of 20 optimization measures as soon as possible through various methods such as video consultation, scheduling and training.
-
How are the pharmaceutical companies doing now after those "sending children to fly solo"?
Time of Update: 2023-01-05
Taking MicroPort, which was spun off and listed by a number of subsidiaries, the company achieved revenue of US$405 million in the first half of the year, a year-on-year increase of 5.
-
Under the screening of innovative pharmaceutical companies, the "weight loss" mode has been opened!
Time of Update: 2023-01-05
In addition, according to incomplete statistics, since October, at least 10 pharmaceutical companies, including Betta Pharmaceutical and Harbour Pharmaceutical, have announced the suspension or termination of new drug research and development projects.
-
The new use of AstraZeneca old medicine attracts attention! What are the implications of "drug concession investment"?
Time of Update: 2023-01-05
Industry experts pointed out that the advantages of drug delivery and drug release technology accumulated by AstraZeneca for many years of research and development are difficult to be surpassed in a short time, but on the other hand, this "on-demand drug delivery" strategy, which truly takes clinical needs as the innovation goal, is what China's innovative pharmaceutical companies should learn from.
-
20 antihypertensive drugs are selling well, and 4 major product brands have broken through!
Time of Update: 2023-01-05
3 major varieties of more than 1 billion are entrenched in the 10 billion market, and 4 domestic brands are listed in the TOP20 Sales of hypertensive drugs in China's urban physical pharmacies in recent years (: 100 million yuan)Source: Competition pattern of drug terminals in China's urban physical pharmacies According to data from Minai.
-
More than 350 pharmaceutical companies have changed their senior management, focusing on chemical drugs, traditional Chinese medicine, APIs and other fields
Time of Update: 2023-01-05
From the perspective of the subdivision track to which these enterprises belong, they are mainly concentrated in the fields of chemical drugs, traditional Chinese medicine, and APIs. In the field of chemical medicine, such as the "first brother of medicine" Hengrui, senior management changes frequently during the year, among which deputy general managers Zhang Yuehong, Zou Jianjun, Tao Weikang, etc.
